Variant report

Variant	esv2763892
Chromosome Location	chr5:167080980-167101161
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BRCA1	chr5:167080881-167081369	Hela-S3	cervix:	n/a	n/a
2	CEBPB	chr5:167090160-167090522	A549	lung:	n/a	chr5:167090340-167090351
3	CEBPB	chr5:167085895-167086223	IMR90	lung:	n/a	n/a
4	CEBPB	chr5:167080752-167081278	A549	lung:	n/a	n/a
5	CEBPB	chr5:167090183-167090486	HepG2	liver:	n/a	chr5:167090340-167090351
6	CEBPB	chr5:167080612-167081349	A549	lung:	n/a	n/a
7	CEBPB	chr5:167080696-167081247	Hela-S3	cervix:	n/a	n/a
8	CEBPB	chr5:167080739-167081159	A549	lung:	n/a	n/a
9	CEBPB	chr5:167090028-167090639	A549	lung:	n/a	chr5:167090340-167090351
10	CEBPB	chr5:167090180-167090586	A549	lung:	n/a	chr5:167090340-167090351
11	CEBPB	chr5:167090152-167090545	Hela-S3	cervix:	n/a	chr5:167090340-167090351
12	CEBPB	chr5:167090273-167090474	H1-hESC	embryonic stem cell:	n/a	chr5:167090340-167090351
13	CEBPB	chr5:167084172-167084590	Hela-S3	cervix:	n/a	n/a
14	CEBPB	chr5:167090159-167090538	IMR90	lung:	n/a	chr5:167090340-167090351
15	CHD2	chr5:167080664-167081246	Hela-S3	cervix:	n/a	n/a
16	CTCF	chr5:167082523-167082590	GM13976	blood:	n/a	n/a
17	CTCF	chr5:167095673-167095681	LNCaP	prostate:	n/a	n/a
18	CTCF	chr5:167101000-167101150	GM12871	blood:	n/a	n/a
19	E2F4	chr5:167081837-167082036	MCF10A-Er-Src	breast:	n/a	n/a
20	E2F4	chr5:167084535-167084648	MCF10A-Er-Src	breast:	n/a	n/a
21	E2F4	chr5:167080825-167081145	MCF10A-Er-Src	breast:	n/a	n/a
22	EBF1	chr5:167092944-167093419	GM12878	blood:	n/a	chr5:167093211-167093222 chr5:167093212-167093222 chr5:167093211-167093224
23	EBF1	chr5:167093067-167093241	GM12878	blood:	n/a	chr5:167093211-167093222 chr5:167093212-167093222 chr5:167093211-167093224
24	EBF1	chr5:167093011-167093319	GM12878	blood:	n/a	chr5:167093211-167093222 chr5:167093212-167093222 chr5:167093211-167093224
25	EP300	chr5:167080636-167081362	A549	lung:	n/a	n/a
26	EP300	chr5:167080760-167081252	Hela-S3	cervix:	n/a	n/a
27	EP300	chr5:167080733-167081280	A549	lung:	n/a	n/a
28	FOS	chr5:167080878-167081232	MCF10A-Er-Src	breast:	n/a	n/a
29	FOS	chr5:167090158-167090497	MCF10A-Er-Src	breast:	n/a	n/a
30	FOS	chr5:167090177-167090527	MCF10A-Er-Src	breast:	n/a	n/a
31	FOS	chr5:167090158-167090514	MCF10A-Er-Src	breast:	n/a	n/a
32	FOS	chr5:167090160-167090522	MCF10A-Er-Src	breast:	n/a	n/a
33	FOS	chr5:167080785-167081246	MCF10A-Er-Src	breast:	n/a	n/a
34	FOS	chr5:167080880-167081249	MCF10A-Er-Src	breast:	n/a	n/a
35	FOS	chr5:167080832-167081246	MCF10A-Er-Src	breast:	n/a	n/a
36	FOSL2	chr5:167080618-167081381	A549	lung:	n/a	n/a
37	FOSL2	chr5:167090068-167090595	A549	lung:	n/a	n/a
38	FOSL2	chr5:167090163-167090401	A549	lung:	n/a	n/a
39	FOSL2	chr5:167080832-167081228	A549	lung:	n/a	n/a
40	FOXA1	chr5:167080892-167081139	T-47D	breast:	n/a	n/a
41	FOXA1	chr5:167084095-167084354	T-47D	breast:	n/a	n/a
42	FOXA2	chr5:167080570-167081271	A549	lung:	n/a	n/a
43	FOXA2	chr5:167080625-167081180	A549	lung:	n/a	n/a
44	FOXP2	chr5:167085941-167086281	SK-N-MC	brain:	n/a	n/a
45	GATA2	chr5:167086047-167086308	SH-SY5Y	brain:	n/a	chr5:167086233-167086250 chr5:167086244-167086251 chr5:167086244-167086251 chr5:167086242-167086251 chr5:167086239-167086255 chr5:167086237-167086258 chr5:167086244-167086251
46	GATA3	chr5:167089756-167089923	SH-SY5Y	brain:	n/a	n/a
47	GATA3	chr5:167084035-167084537	T-47D	breast:	n/a	n/a
48	GATA3	chr5:167090943-167091250	T-47D	breast:	n/a	n/a
49	GATA3	chr5:167086140-167086328	SH-SY5Y	brain:	n/a	chr5:167086233-167086250 chr5:167086244-167086251 chr5:167086244-167086251 chr5:167086242-167086251 chr5:167086239-167086255 chr5:167086237-167086258 chr5:167086244-167086251
50	GATA3	chr5:167080620-167081448	A549	lung:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr5:167088724-167088774	HCF	heart:	n/a
2	chr5:167097366-167097416	HCPEpiC	choroid plexus:	n/a
3	chr5:167088724-167088774	AG10803	skin:	n/a
4	chr5:167097366-167097416	SKMC	muscle:	n/a
5	chr5:167097366-167097416	SK-N-SH_RA	brain:	n/a
6	chr5:167088724-167088774	SK-N-SH_RA	brain:	n/a
7	chr5:167088724-167088774	HCT-116	colon:	n/a
8	chr5:167097366-167097416	PANC-1	pancreas:	n/a
9	chr5:167097366-167097416	AoSMC	blood vessel:	n/a
10	chr5:167088724-167088774	H1-hESC	embryonic stem cell:	embryo
11	chr5:167097366-167097416	NH-A	brain:	n/a
12	chr5:167097366-167097416	NB4	blood:	n/a
13	chr5:167088724-167088774	PFSK-1	brain:	n/a
14	chr5:167097366-167097416	NHBE	bronchial:	n/a
15	chr5:167097366-167097416	MCF10A-Er-Src	breast:	n/a
16	chr5:167088724-167088774	HRPEpiC	eye:	n/a
17	chr5:167097366-167097416	HUVEC	blood vessel:	n/a
18	chr5:167097366-167097416	Caco-2	colon:	n/a
19	chr5:167097366-167097416	HL-60	blood:	n/a
20	chr5:167088724-167088774	K562	blood:	n/a
21	chr5:167088724-167088774	U87	brain:	n/a
22	chr5:167088724-167088774	BE2_C	brain:	n/a
23	chr5:167097366-167097416	HRE	kidney:	n/a
24	chr5:167088724-167088774	MCF-7	breast:	n/a
25	chr5:167088724-167088774	NH-A	brain:	n/a
26	chr5:167097366-167097416	HCF	heart:	n/a
27	chr5:167088724-167088774	Caco-2	colon:	n/a
28	chr5:167088724-167088774	ECC-1	luminal epithelium:	n/a
29	chr5:167088724-167088774	GM19239	blood:	n/a
30	chr5:167097366-167097416	Hela-S3	cervix:	n/a
31	chr5:167097366-167097416	AG09309	skin:	n/a
32	chr5:167097366-167097416	H1-hESC	embryonic stem cell:	embryo
33	chr5:167088724-167088774	SKMC	muscle:	n/a
34	chr5:167097366-167097416	GM06990	blood:	n/a
35	chr5:167097366-167097416	HEEpiC	esophagus:	n/a
36	chr5:167097366-167097416	LNCaP	prostate:	n/a
37	chr5:167088724-167088774	SK-N-SH	brain:	n/a
38	chr5:167088724-167088774	AG09319	gingival:	n/a
39	chr5:167097366-167097416	ProgFib	skin:	n/a
40	chr5:167088724-167088774	Hela-S3	cervix:	n/a
41	chr5:167097366-167097416	SK-N-MC	brain:	n/a
42	chr5:167088724-167088774	HAEpiC	amniotic membrane:	n/a
43	chr5:167088724-167088774	HEK293	kidney:	embryo
44	chr5:167088724-167088774	Hepatocyte	liver:	n/a
45	chr5:167097366-167097416	ECC-1	luminal epithelium:	n/a
46	chr5:167097366-167097416	RPTEC	kidney:	n/a
47	chr5:167088724-167088774	ovcar-3	ovarian:	n/a
48	chr5:167097366-167097416	AG04449	skin:	fetal
49	chr5:167097366-167097416	AG10803	skin:	n/a
50	chr5:167097366-167097416	CMK	blood:	n/a

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-PANK3-6	chr5:167087063-167087486	ENSG00000254187.1

Variant related genes	Relation type
ENSG00000254187	TF binding region
ENSG00000254187	CpG island

Extended variants
information (count: 760 )
Associated
traits (count: 80 )

Variant overlapped rSNPs/rCNVs (count:760 , 50 per page) page: 1 2 3 4 5 6 7 ... 16

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs369774538	chr5:167081076-167081077	Weak transcription Strong transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
2	rs528241097	chr5:167081077-167081078	Weak transcription Strong transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs542036098	chr5:167081114-167081115	Weak transcription Strong transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs201411837	chr5:167081135-167081136	Weak transcription Strong transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs569241709	chr5:167081136-167081137	Weak transcription Strong transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs150323728	chr5:167081195-167081196	Weak transcription Strong transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs73801314	chr5:167081206-167081207	Enhancers Weak transcription Strong transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
8	rs550823849	chr5:167081207-167081208	Enhancers Weak transcription Strong transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs146409859	chr5:167081218-167081219	Enhancers Weak transcription Strong transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs140815069	chr5:167081342-167081343	Enhancers Weak transcription Strong transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs145869110	chr5:167081353-167081354	Enhancers Weak transcription Strong transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs566624182	chr5:167081373-167081374	Enhancers Weak transcription Strong transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs535597262	chr5:167081430-167081431	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs143614977	chr5:167081452-167081453	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs202117076	chr5:167081460-167081461	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs17509347	chr5:167081501-167081502	Enhancers Weak transcription Strong transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
17	rs182183929	chr5:167081508-167081509	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs538063842	chr5:167081531-167081532	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs73801315	chr5:167081534-167081535	Enhancers Weak transcription Strong transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
20	rs73801316	chr5:167081564-167081565	Enhancers Weak transcription Strong transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
21	rs185670520	chr5:167081565-167081566	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs552733533	chr5:167081601-167081602	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs549820765	chr5:167081613-167081614	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs572958349	chr5:167081626-167081627	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs541974732	chr5:167081666-167081667	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs561788614	chr5:167081674-167081675	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs575477810	chr5:167081712-167081713	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs115937077	chr5:167081736-167081737	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs35143859	chr5:167081768-167081769	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs564361137	chr5:167081814-167081815	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs573048782	chr5:167081815-167081816	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs568099255	chr5:167081838-167081839	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs72821806	chr5:167081843-167081844	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
34	rs546966965	chr5:167081862-167081863	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs560150713	chr5:167081869-167081870	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs75698696	chr5:167081901-167081902	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs549028294	chr5:167081922-167081923	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs564980944	chr5:167081925-167081926	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs370666767	chr5:167081939-167081940	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs569017020	chr5:167081971-167081972	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs190392140	chr5:167082004-167082005	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs17068914	chr5:167082005-167082006	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
43	rs551734150	chr5:167082030-167082031	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs571898816	chr5:167082039-167082040	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs182201761	chr5:167082078-167082079	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs186683040	chr5:167082083-167082084	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs191101199	chr5:167082102-167082103	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs116749824	chr5:167082123-167082124	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs143095181	chr5:167082147-167082148	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs534137082	chr5:167082177-167082178	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:80)

Disease	PMID	Source
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Medulloblastoma	21979893	CNVD
Phyllodes tumor	17334353	CNVD
Malaria	21533027	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	20164919	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Cancer	16751803	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Melanoma	18172304	CNVD
Glioma	20126413	CNVD
Cancer	22429812	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Liposarcoma	21253554	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Breast cancer	21858162	CNVD
Leukemia	17361228	CNVD
Myelodysplastic syndrome	18508791	CNVD
5q-syndrome	17576883	CNVD
Gastric cancer	17908304	CNVD
Lung cancer	16740712	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Urothelial carcinoma	21177765	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Barrett''s syndrome	19417022	CNVD
Lung cancer	18438408	CNVD
Thyroid cancer	19087340	CNVD
Breast cancer	21785460	CNVD
Breast cancer	17133270	CNVD
Acute myeloid leukemia	20729466	CNVD
lymphocytic leukemia	21291569	CNVD
Acute myeloid leukemia	21251322	CNVD
Multiple myeloma	17550852	CNVD
Salivary gland tumor	18059337	CNVD
Renal cell carcinoma	19377443	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Renal cell carcinoma	18592004	CNVD
Hodgkin''s lymphoma	17606441	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Breast cancer	17603634	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Prostate cancer	18632612	CNVD
Ovarian cancer	21720365	CNVD
Myelofibrosis	22110671	CNVD
severe myoclonic epilepsy of infancy	18294202	CNVD
Olfactory neuroblastoma	18408657	CNVD
Esophageal squamous carcinoma	17470683	CNVD
Mental retardation	17124404	CNVD
epilepsy	18472482	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:147 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr5:167067200-167084200	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
2	chr5:167079000-167081000	Enhancers	NHDF-Ad	bronchial
3	chr5:167079000-167081400	Enhancers	HSMM	muscle
4	chr5:167079000-167081600	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
5	chr5:167079000-167081600	Enhancers	Osteobl	bone
6	chr5:167079200-167081600	Enhancers	Hela-S3	cervix
7	chr5:167079400-167081400	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
8	chr5:167079400-167081400	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
9	chr5:167079400-167081400	Enhancers	NHEK	skin
10	chr5:167079600-167081400	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
11	chr5:167079600-167081400	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
12	chr5:167079600-167081600	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
13	chr5:167079600-167081600	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
14	chr5:167079800-167081400	Enhancers	HMEC	breast
15	chr5:167079800-167081600	Enhancers	NH-A	brain
16	chr5:167080000-167081000	Enhancers	HSMMtube	muscle
17	chr5:167080000-167081600	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
18	chr5:167080200-167081000	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
19	chr5:167080600-167081000	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
20	chr5:167080600-167081000	Genic enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
21	chr5:167080600-167081400	Flanking Active TSS	Muscle Satellite Cultured Cells	--
22	chr5:167080600-167081400	Flanking Active TSS	A549	lung
23	chr5:167080600-167081600	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
24	chr5:167080800-167081400	Enhancers	Aorta	Aorta
25	chr5:167080800-167084000	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
26	chr5:167081000-167081800	Strong transcription	H9 Derived Neuron Cultured Cells	ES cell derived
27	chr5:167081200-167081600	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
28	chr5:167081400-167081800	Enhancers	Muscle Satellite Cultured Cells	--
29	chr5:167081400-167082800	Enhancers	A549	lung
30	chr5:167081400-167085000	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
31	chr5:167081400-167090400	Weak transcription	HSMM	muscle
32	chr5:167081600-167081800	Enhancers	Pancreatic Islets	Pancreatic Islet
33	chr5:167081600-167084000	Weak transcription	Hela-S3	cervix
34	chr5:167081600-167085600	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
35	chr5:167081600-167086200	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
36	chr5:167081600-167089800	Weak transcription	Osteobl	bone
37	chr5:167081800-167082400	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
38	chr5:167081800-167082400	Weak transcription	Pancreatic Islets	Pancreatic Islet
39	chr5:167081800-167085800	Weak transcription	Muscle Satellite Cultured Cells	--
40	chr5:167082400-167082600	Strong transcription	H9 Derived Neuron Cultured Cells	ES cell derived
41	chr5:167082400-167083400	Enhancers	Pancreatic Islets	Pancreatic Islet
42	chr5:167082600-167082800	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
43	chr5:167082800-167084200	Weak transcription	A549	lung
44	chr5:167082800-167086800	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
45	chr5:167083400-167088200	Weak transcription	Pancreatic Islets	Pancreatic Islet
46	chr5:167084000-167084400	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
47	chr5:167084000-167085000	Enhancers	Hela-S3	cervix
48	chr5:167084200-167084600	Flanking Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
49	chr5:167084200-167084600	Enhancers	A549	lung
50	chr5:167084600-167085000	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links